# A Bioavailability Study of FL-101 in Healthy Male and Female Subjects

> **NCT04983732** · PHASE1 · COMPLETED · sponsor: **Flame Biosciences** · enrollment: 24 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** FL-101-Intravenous
- **DRUG:** FL-101-Subcutaneous

## Key facts

- **NCT ID:** NCT04983732
- **Lead sponsor:** Flame Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-11
- **Primary completion:** 2022-05-05
- **Final completion:** 2022-05-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04983732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04983732, "A Bioavailability Study of FL-101 in Healthy Male and Female Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04983732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*